PETROSCRAP.COM

mPhase Technologies Patent Portfolio Potential and Strategy Explained in Boston Investor Meetings LITTLE FALLS, NJ–(Marketwire – June 22, 2010) – mPhase Technologies, Inc. ( OTCBB : XDSL ) will hold a series of investor meetings in Boston tomorrow, June 23, during which CEO Ron Durando will explain the Company’s strategy for monetizing its new U.S. patent. Read more on…. Click Here to Read More

PURE Bioscience Granted Patent for Anhydrous SDC SAN DIEGO—-PURE Bioscience today announced that the United States Patent and Trademark Office issued patent number 7,732,486, which covers PURE’s anhydrous silver dihydrogen citrate technology. Read more on Business Wire via Yahoo!…. Click Here to Read More

Silence Therapeutics Issued Novel RNAi Patent Covering High-Value Cancer Target in United States Silence Therapeutics plc (AIM: SLN) (“Silence” or the “Company”) announces the issuance of United States patent 7,723,316, titled Compositions and Methods of RNAi Therapeutics For Treatment of Cancer and Other Neovascularization Disease, by the United States Patent and Trademark Office (USPTO). The issued patent, which deepens the Company’s diverse portfolio of RNA interference (RNAi … Read more on SYS-CON…. Click Here to Read More

Open house for Tri-Valley’s girls program Feb. 23 Seventh- and eighth-grade girls and their parents are invited to the seventh annual Reflections on Your Future event. The event is an introduction to a program designed to encourage girls to pursue interests in technology, science, math and engineering. Read more on Contra Costa Times ISA Technovation Awards 2010 announced BANGALORE, INDIA: At a gala award night here, India Semiconductor Association, the semiconductor-driven industry body of the country, on Monday announced Technovation Awards for the year 2010. Read more on CIOL EPO to grant patent notice to BioMimetic Therapeutics BioMimetic Therapeutics, Inc. announced…. Click Here to Read More